Phytoestrogens. Friends or foes? by Barrett, J
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Phytoestrogens are plant chemi-
cals that may act as fungicides,
deter herbivores, regulate plant
hormones, and protect plants
against ultraviolet radiation.
Structurally, some phytoestrogens
resemble endogenous estrogens ofhumans
and animals, and recent research suggests
they may also function as estrogen agonists
or antagonists when eaten by humans.
Although humans have used phytoestro-
gens medicinally for thousands of years,
only in the last 15 years or so have
researchers begun to look beyond the folk
remedies to investigate phytoestrogens'
possible roles in modern health care.
Although the popular media has at times
heralded phytoestrogens as panaceas, med-
ical data remain inconclusive. Still, recent
epidemiological studies and experiments
with animals suggest many varied benefits
of phytoestrogens. "Although much
indepth research has been done to identify
and characterize the pharmacokinetics of
certain phytoestrogens, the whole area of
using phytoestrogens for medicinal purpos-
es remains wide open," says Retha
Newbold, a research biologist in the
NIEHS Reproductive Toxicology Group.
Reports about environmental estro-
gens, or xenoestrogens, have been wide-
spread in the last few years. There are
important distinctions between estrogenic
compounds of industrial origin and those
that come from plants, however.
Compounds such as the insecticide DDT
and industrial PCBs have been implicated
by some researchers in causing estrogen-
dependent cancers in exposed populations.
These same compounds have also been
suggested as causes of declining sperm
counts and other fertility problems in
humans, as well as reproductive failures
and anatomical abnormalities in wildlife.
Unlike some industrial xenoestrogens,
which tend to bioaccumulate in adipose
tissue and persist in the body for years,
phytoestrogens are readily metabolized and
spend relatively little time in the body.
However, during this time they can have
significant effects on body systems. The
timing of exposure, repeated exposures,
and levels of exposure to phytoestrogens
are important. "The issue is a lot more
complicated than it looks on the surface,"
says Newbold. "Just because a substance,
like phytoestrogens, is naturally produced
doesn't make it automatically harmless or
beneficial."
HowTheyWork
Extensive research has been done to identify
the types ofphytoestrogens that are found
in humans and how they are metabolized.
The two major classes of phytoestrogens
that have captured the most scientific atten-
tion are lignans and isoflavones. Kenneth
Setchell, associate professor ofpediatrics at
the University of Cincinnati Children's
Hospital, began studying phytoestrogens in
the early 1980s. For several years Setchell
and his colleagues had been puzzled by
unknown steroids in biological fluids. As
part ofa study on hormonal fluctuations in
women, he began investigating urinary
steroid hormone metabolites. A closer look
E at these compounds prompted
speculation that theymight be pre-
viously unidentified endogenous
estrogens. Therefore, it came as a
surprise when two independent
research groups identified thecompounds as
lignans, which weren't known to exist in
humans. The two lignans, named enterolac-
tone and enterodiol, are actually the prod-
ucts ofmicrobial metabolism ofsecoisolari-
ciresinol and matairesinol, compounds
found inwhole grains, fibers, and flax seeds,
as well as several fruits and vegetables.
Enterodiol may be further oxidized to
enterolactone. All four of the lignans may
be absorbedfrom thegut.
Isoflavones, which are abundant in
legumes, have also been identified in
human biological fluids. Within plant tis-
sues, isoflavones exist as sugar derivatives
called glycosides, and concentrations vary
widely depending on stressors such as viral,
bacterial, fungal, or herbivore attack. These
compounds undergo hydrolysis in the
human gut, yielding aglycones. Like the
lignans, these aglycones meet one of three
fates: they may be excreted or absorbed
from the gut, or undergo further metabo-
lism. The four most common isoflavones
are formononetin, daidzein, genistein, and
biochanin A. Biochanin A is metabolized
to genistein. If it is not absorbed into the
body, it may be further metabolized to p-
ethylphenol, a hormonally-inert com-
pound. Formononetin may be metabolized
to daidzein, which is further metabolized
mostly to equol, a more potent phytoestro-
gen, and to 0-desmethylangolensin.
Products of both lignan and isoflavone
metabolism may be excreted or absorbed.
If absorbed, the phytoestrogens undergo
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conjugation in the liver with glucuronic
acid, or to a lesser extent, sulfate, and are
excreted in the urine or in the bile. Some
intestinal bacteria produce f-glucuronidas-
es, enzymes that can deconjugate phytoe-
strogen metabolites when they pass
through the intestine, setting the stage for
their recirculation through the body.
Nonsteroidal plant estrogens were first
identified in the early 1930s, with the dis-
covery that soybeans, willows, dates, and
pomegranates contain compounds with
structural similarity to estrogens. It was
unknown whether these compounds could
have biological activity in animals until a
concurrent discovery was made in phytoe-
strogens' effects onAustralian sheep. Female
sheep were plagued by reproductive system
lesions and sharp declines in fertility.
Animal husbandry experts linked the prob-
lem to the sheep's grazing on Trifolium sub-
terraneum, a species of clover. Researchers
identified the clover compounds equol and
coumestrol (another phytoestrogen) as
being responsible for the sheep's reproduc-
tive problems. Once the etiology of clover
disease had been established, scientists
began to question whether these com-
pounds also affected other species. Equol
and other phytoestrogens such as enterolac-
tone and enterodiol were discovered in
human biological fluids in concentrations as
much as 5,000 times greater than endoge-
nous estrogens. The question then became
whether these compounds presented a
reproductive or other risk to humans or
whether their presence might be in some
way beneficial. "Unless you ask what is the
quantitative risk [of phytoestrogens]," says
Michael Bolger, a toxicologist at the FDA's
Center for Food Safety and
Applied Nutrition, "how
can you integrate it with
the benefits to get the full
picture?"
Benefits
Scientists have begun to
piece together the full pic-
ture of phytoestrogens by
looking at populations who
consume them the most.
Asian populations consume
a diet that is very rich in
the phytoestrogens genis- Retha ewbold-l
tein and daidzein, which substances are n
are found in soybeans and harmless orbenel
soy products. These phy-
toestrogens occur at levels of 50-300 mil-
ligrams per 100 grams in soy beans, and in
lower levels in soy products such as miso,
soy milk, and tofu.
Asian populations also suffer a signifi-
cantly lower rate of hormone-dependent
cancers compared to westerners. They also
have a much lower incidence ofother hor-
monally-associated problems such as osteo-
porosis and menopausal symptoms. The
presence of phytoestrogens in Asian diets
and the comparatively low rates ofdiseases
prevalent in western populations-includ-
ing breast, endometrial, prostate, and colon
cancers, as well as coronary heart disease-
suggests that phytoestrogens may have pro-
tective effects.
Studies of immigrants have bolstered
the argument that different disease rates
between eastern and western populations
may spring more from diet than from
other factors, such as genetics. Although
\atu
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the genetic link to several
cancers has been well estab-
lished, the genetic propensity
to develop cancer does not
vary significantly between
eastern and western popula-
tions. For example, Japanese
mendevelop small latent pro-
static carcinomas at the same
rate as western men, although
their mortality from prostate
cancer is much lower.
However, Asian immigrants
to western countries tend to
rally-produced alter their diets to the typical
automatically western diet that includes
al. more protein and fat, less
fiber, and fewer soy products.
As their diets change, their risks for certain
hormonally-related diseases increase.
These effects may be due to certain
properties of phytoestrogens. For example,
lignans are associated with the fiber por-
tion of seeds and grains. Because fiber
increases fecal bulk and decreases intestinal
3-glucuronidase levels, it reduces the circu-
lation of conjugated estrogens in the liver
and intestines. By indirectly reducing the
amount of bioavailable hormone, fiber
may reduce cancer risk.
Other research has focused on the effects
of a lack ofbeneficial dietary factors rather
than the presence of detrimental compo-
nents. Herman Adlercreutz, professor and
chairman of the Department of Clinical
Chemistry at the University of Helsinki,
reviewed phytoestrogens in articles in the
October 1995 EHP Supplement and (with
colleagues) the March 1995 supplement of
theJournalofNutrition. Adlercreutz present-
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Puzzle pieces. The structures of some of the most important phytoestrogens
for humans have been identified. Source: Adlercreutz H. Phytoestrogens: epi-
demiology and a possible role in cancer protection. Environ Health Perspect
Suppl, 103(7):103-112(1995). Enterolactone Enterodiol
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ed evidence from many
studies which shows that
lignan and isoflavonoid
excretion rates correlate
with dietary and population
groups. People who ate a
macrobiotic diet and vege-
tarians had significantly
higher urinary excretion
rates oflignans compared to rn 5%
meat eaters and subjects $ 1%
with breast cancer. Low uri- W
nary lignan values were also
seen in Japanese men and K
women, consistent with
their low consumption of
whole grain products. This
group's high consumption of Soy surprise. Americans may be reaping the benefits of soybeans by eating more of
soy products was reflected in themthantheythink.
their high urinary and plas-
ma concentrations of isoflavonoids.
Metabolites of phytoestrogens in biological
fluids indicated that people who consumed
phytoestrogens in their diets also metabo-
lizedand absorbed them.
Results showing that variations exist
among dietary and population groups
with regard to plasma, urinary, and fecal
concentrations of estrogens and estrogen
metabolites provide some evidence that
phytoestrogens affect sex hormone metab-
olism. How these differences relate to dis-
ease rates is being investigated.
In Vitro andAnimal Studies
Many of the studies that provide evidence
for the benefits ofphytoestrogens were con-
ducted for the purpose of
investigating other end-
points and, therefore, are
not accepted as definitive.
"These studies addweight to
the questions, but they don't
answer them," cautions
Daniel Sheehan, research
biologist, at the National
Center for Toxicological
Research. Still, in vitro stud-
ies have served as a spring-
board for phytoestrogen
research.
In vitro studies using
radiolabelled estradiol have Daniel Sheeha
helped to demonstrate that of phytoestrog
phytoestrogens and endoge- nosafet studie
nous estrogens have a com-
mon mechanism ofaction, namely through
the estrogen receptor. It has been shown
that phytoestrogens can elicit both estro-
genic and antiestrogenic responses.
According to Newbold, most researchers
accept that phytoestrogens such as lignans
and isoflavones are weakly estrogenic. For
example, the equilibrium dissociation con-
n-)
lens
es h
stant for genistein is 100 to 10,000 times
greater than for estradiol or DES, which
means that genistein's ability to stay bound
to an estrogen receptor is less than one-hun-
dredth that of the more potent estrogens.
Furthermore, if genistein binds with an
estrogen receptor, it elicits less than one-
thousandth the response of an endogenous
estrogen.
In vitro data have demonstrated that
phytoestrogens may inhibit cell cancer
growth. For example, using the MCF-7
human breast cancer cell line, which
depends on estrogen for proliferation,
researchers have shown that the lignan
enterolactone inhibits proliferation in the
presence of estradiol, a stronger estrogen.
Alone, enterolactone stimu-
_ lates proliferation.
In vitro data have also
demonstrated biological
activity by phytoestrogens
that is not associated with
estrogenicity, namely inhi-
bition of protein tyrosine
kinases, DNA topoiso-
merases, and angiogenesis
by genistein. Of particular
interest are reports of inhi-
bition of protein tyrosine
kinase, an enzyme associat-
ed with oncogene products
-While benefits of the retroviral src gene
are intriguing, family. Such variety in bio-
ave been done. logical action might explain
why genistein is able to
inhibit cancer cell growth in both the
estrogen-dependent MCF-7 and estrogen-
independent MDA-468 breast cancer cell
lines. Other effects include stimulation of
sex hormone-binding globulin (SHBG)
synthesis and inhibition ofaromatase, both
of which indirectly affect the amount of
free steroidal hormones in the body. Also,
some evidence exists for
inhibition of 17p-hydroxys-
teroid oxidoreductase type I,
the enzyme responsible for
reversible conversion of17p-
estradiol to estrone. In addi-
tion to the inhibiting cancer
cell growth, genistein has
also been shown to induce
differentiation of cells into
mature phenotypes.
The in vitro studies have
provided the basis for in vivo
studies of phytoestrogens.
Most such in vivo studies
have been conducted in rats
and mice, but some have
been conducted on nonhu-
man primates. These studies
highlight the difficulties in
extrapolating from in vitro results to whole
systems. For example, in a 1994 study in
Anticancer Research, oncologist Harmesh R.
Naik and colleagues at Wayne State
University School ofMedicine compared in
vitro and in vivo data on genistein's ability
to affect hormone refractory prostate can-
cer. Although genistein was cytotoxic in
both rat and human prostate cancer cell
lines, it failed to inhibit proliferation of
implanted prostate cells in rats.
Experimental Studies in Humans
Researchers are becoming fascinated by
phytoestrogens' potential as cancer preven-
tatives and as nonpharmaceutical interven-
tions for menopausal symptoms and osteo-
porosis. Current estrogen replacement
therapies treat menopausal symptoms and
may help to prevent health problems such
as breast and endometrial cancers and
osteoporosis. Many women are reluctant to
take estrogenic drugs because ofside effects
such as resumption of menstrual bleeding,
breast tenderness, and weight gain. The
first studies in this area have focused on
whether dietary amounts ofphytoestrogens
are sufficient to alter menstrual cycles.
Aedin Cassidy and colleagues at the Dunn
Clinical Nutrition Center in Cambridge,
England, investigated the effect of a high
soy-protein diet on hormonal status and
the menstrual cycles of nine women
between the ages of 21 and 29. In a study
published in the September 1994 issue of
the AmericanJournal ofClinical Nutrition,
they found that ingesting 60g of soy pro-
tein (equivalent to 45mg of isoflavones)
daily for 1 month was sufficient to disrupt
the menstrual cycle by increasing the
length of the follicular phase and delaying
the onset ofmenstruation. Flax seed, a rich
source of lignans, has also been demon-
strated to induce cycle changes.
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Results ofsome studies related to possible anticancer effects of isoflavonoids and lignans
Type of cancer
Breast cancer
Breast cancer
Breast cancer
Breast cancer
Breast cancer
Breast cancer
Colon cancer
Colon cancer
Gastric cancer
Gastric, esophagus,
colon cancer
Livercancer
Uver cancer
Prostate cancer
Prostatitis
Prostatic dysplasia
Leukemia
Leukemia
Myeloid leukemia
Melanoma
Embryonal carcinoma
Solid pediatrictumors
Placentalmicrosomes
Endothelial cells
Compound orfood
Genistein
Dietand phytoestrogen
excretion
Soy bean chips
Flaxseed
Genistein, biochanin A
Enterolactone
Species or cell type
MCF-7 cells
Women
Rat
Rat
MCF-7 + othercells
MCF-7 cells
Soyintake Japanese men,women
Flaxseed Rat
Genistein HGC-27 cells
Genistein, biochanin A Manytypes ofcells
Genistein
Enterolactone
Soyproducts
Soyfood
Soyfood
Genistein
Genistein
Daidzein
Genistein
Genistein
Genistein
Lignans
Genistein
HepG2cells
HepG2cells
Men ofJapanese ance
Rat
Male mice
Effect or result
Competition with estradiol
Low urinary excretion in
women at higher risk
Inhibition oftumorgrowth
Protective
Inhibition ofproliferation
Inhibition ofproliferation in
the presence ofestradiol
Reduced risk
Protective
Growth inhibition
Inhibition ofproliferation
Inhibition ofproliferation
StmulationofSHBG
synthesis
stry Less risk
Preventive effect
Inhibition
MOLT-4, HL-60human cells Inhibits cell cycle,
progression, andgrowth
Human HL-60, K562 cells Inducton ofdifferentiation
HL-60cells Induction ofdifferentiation
5 cell lines Induction ofdifferentiation
Mouse F9Cells Induction ofdifferentiation
Neuroblastoma, sarcoma Inhibition ofproliferation
Human Inhibition ofaromatase
Manydifferent Inhibition ofangiogenesis
endothelial cells
Source: Adlercreutz H, Phytoestrogens: Epidemiology and a possible role in cancer protection.
Environ Health PerspectSuppl, 103(7):103-112(1995).
Experiments with menopausal women
have been less conclusive. Epidemiologist
Donna Baird and colleagues at the NIEHS
looked at a variety ofmeasurements in an
attempt to determine the estrogenicity of
dietary soy in postmenopausal women in a
study published in the May 1995 issue of
the Journal ofClinical Endocrinology and
Metabolism. After consuming a soy diet
including 165 mg of isoflavones daily for
one month, the subjects showed very little
estrogenic response: levels of follicle-stim-
ulating hormone, luteinizing hormone,
and SHBG did not change significantly.
There was a small effect on the maturation
ofthe vaginal epithelium.
Setchell, who was involved with the
study, speculated that more effect might
have been shown if the experiment had
lasted longer, citing an Australian study
that ran for three months. This study,
which appeared in the April 1995 issue of
Maturitas, was conducted by Alice L.
Murkies, a doctor of medicine at the
Brighton Medical Clinic in Victoria,
Australia. Murkies and colleagues mea-
sured hot flashes as a determinant ofestro-
genic activity in response to phytoestrogen-
rich diets. This experiment found signifi-
cant reductions in the occurrence of hot
flashes when the diets of postmenopausal
women were supplemented with soy or
wheat flours for 12 weeks. Of the test
diets, soy seemed to yield the best results,
but the authors did not indicate the
amounts of actual phytoestrogens the test
subjects consumed on a daily basis.
Neither soy nor lignans have been exam-
ined for protective effects against osteo-
porosis. However, ipriflavone, a phytoe-
strogen similar to genistein, has been
shown to stimulate osteoblasts.
Human studies on hormones and diet
may be confounded by a number oflargely
uncontrollable variables including genetics,
individual intestinal flora, transit time,
effects ofmedicines, health, and hormonal
status. Many of the diseases being studied
for phytoestrogenic effects are also multi-
factorial. Researchers have indicated that a
prospective study is needed to tease out
phytoestrogens' effects.
Risks
Although studies on phytoestrogenic bene-
fits seem promising, researchers have
voiced concerns that consumption oflarge
amounts of phytoestrogens may cause
adverse health effects, especially with
regard to development and fertility. "My
position is that, while we are intrigued by
the possible benefits, the fact ofthe matter
is that no safety studies, especially with
regard to development, have been done,"
says Sheehan. "Estrogens are clearly a two-
edged sword in humans." Newbold also
expresses concern that the effects ofdevel-
opmental exposure to phytoestrogens is
simply not known. "We are not sure for
adults if the 'natural' doses are helpful, or
at least not harmful." Also, the possible
interactions of phytoestrogens with estab-
lished medical treatments such as estrogen
replacement therapy or cancer therapy are
unknown.
Neonatal and in utero exposures to sex
steroids regulate the development of sexu-
ally differentiated behavior, reproductive
physiology, and central nervous system
anatomy and neurochemistry. In a letter
published in the 24 May 1995 issue ofthe
New ZealandMedicalJourna4 Cliff Irvine,
a professor of animal and veterinary sci-
ence, and colleagues at Lincoln University
in New Zealand indicated that soy-based
infant formulas in New Zealand contain
3-5 times as much daidzein and genistein
as the amount that will disrupt a woman's
menstrual cycle. Considering diethylstilbe-
strol's estrogenic effects on development,
Irvine stated that this exposure should be
investigated. Setchell says that infants
metabolize the phytoestrogens, but how
these compounds act in their bodies is
unknown. One point of view is that they
might negatively affect development, while
others believe developmental effects would
be negligible, and that exposure might
actually help ward off hormone-related ill
health in the future.
Patricia Whitten, an associate professor
of anthropology, and colleagues at Emory
University have investigated possible devel-
opmental effects of coumestrol. Results of
the study, published in the March 1995
supplement to the Journal ofNutrition,
showed that in neonatal and immature
rats, endogenous estrogens were low, and
that coumestrol induced estrogenic
responses, including premature estrous
cycles. In normal adult female rats, coume-
strol proved antagonistic to the endoge-
nous estrogens and disrupted the ovarian
cycle. Whitten and colleagues have also
found that male and female neonatal rats
exposed to coumestrol via their mothers'
milk had altered numbers of progestin
receptors in the pituitary and hypothala-
mus, as well as altered sexual behavior and
gonadotropin function. These results led
researchers to conclude that coumestrol has
a negative effect on neuroendocrine devel-
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opment. Although coumestrol has shown
fertility and developmental effects, it's dif-
ficult to extrapolate these results to
humans, whose exposure to coumestrol is
dwarfed by their exposures to genistein,
daidzein, and lignans.
Very little research has examined genis-
tein's effect on development outcomes.
Claude Hughes, now an associate professor
of comparative medicine and obstetrics
and gynecology at the Bowman Gray
School of Medicine at Wake Forest
University, examined neonatal exposure to
genistein while working at Duke
University Medical Center. Hughes and
colleague Jill R. Levy in Duke's
Department ofObstetrics and Gynecology
found that exposure to genistein disrupted
secretion of luteinizing hormone by the
pituitary gland. In a recent paper published
in the January 1995 issue of the
Proceedings ofthe Societyfor Experimental
Biology andMedicine, Levy and colleagues
revealed that in utero exposure of rats to
genistein may decrease markers such as
birth weight and anogenital distance, and
in female rats may delay the onset of
puberty. Though these results do not con-
firm any risks for human infants, they do
not discount them either.
Coral Lamartiniere, a professor of
pharmacology and toxicology at the
University of Alabama, and other
researchers offer the argument that early
exposure to genistein might actually be
beneficial. In one study, published in the
January 1995 issue ofthe Proceedings ofthe
Society for Experimental Biology and
Medicine, Lamartiniere and colleagues
injected neonatal rats with genistein. Once
the rats reached maturity, they were
exposed to dimethylbenz[a]anthracene to
induce mammary carcinogenesis. Rats that
had been exposed to genistein as neonates
had significantly increased latency in devel-
oping tumors, as well as reduced incidence
of tumors. Lamartiniere said similar
chemopreventive results were observed in
rats exposed to genistein during puberty
only. Despite lengthening their estrous
cycles, their follicular development, sex
steroid concentrations, and fertility seemed
fine. "Common sense would tell us that
soy does not pose a problem for fertility,"
said Setchell, pointing to the reproductive
success ofAsians. However, he added, that
fact could be countered with other similar-
ly logical arguments. One such argument,
according to Hughes, is that Asians have
been consuming these diets for centuries,
and any soy-related fertility problems may
have been selectively bred out ofthe popu-
lation generations ago. In that case, west-
erners suddenly switching to a soy-based
diet might not have the advantage of that
natural selection. Sheehan also adds that,
especially with developmental toxicants,
there is a long latency period, which makes
it difficult to associate an event with a neg-
ative outcome. "The fact that there aren't
any negative reports can't be taken as an
argument that soydiets are safe," he said.
The current knowledge base on phy-
toestrogens fuels speculation and argu-
ments, but doesn't yield definitive answers.
For all the varying opinions about phytoe-
strogens, however, researchers are united in
the call for more definitive research. "What
seems eye-opening to me is that we are
looking at the development ofa field," says
Newbold. "It's just now come to the fore-
front."
Julia Barrett
41stAnnual Institute in Water
Pollution Control
Manhattan College
Riverdale, NY
June 3-7, 1996
Manhattan College's forty-first annual Institute in Water Pollution Control will take place on June 3-7, 1996 in the
Manhattan College Leo Engineering Building, Riverdale, New York. Two courses, which run concurrently, will be
offered: Modern Eutrophication Modeling, and Treatment of Municipal, Hazardous and Toxic Wastewaters. These
week-long courses have much to offer young engineers and seasoned professionals who have not been able to stay
abreast of the rapidly changing field. Set in a classroom atmosphere, the courses allow for dialog between lecturer
and participants. The fee per course is $1,150 and includes a set of notes for each attendee.
For a brochure ofadditional information,
contact: Ms. Lucia Chiocchio,
Program Coordinator, Manhattan College,
Environmental Engineering Department, Riverdale, NY 10471
Phone (718) 920-0277 FAX (718) 543-7914
482 Volume 104, Number5, May 1996* EnvironmentalHealth Perspectives